Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2018 04:00 ET | Source: Helsinn Healthcare S.A.

Helsinn and CJ Healthcare announce the approval of AKYNZEO® oral formulation in Korea

Helsinn and CJ Healthcare announce the approval of AKYNZEO® oral formulation in Korea CINV is one of the most common and distressing side effects of cancer chemotherapyIncluded as a treatment option...